| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/05/1997 | US5653993 Procedure for encapsulating ibuprofen |
| 08/05/1997 | US5653989 Lotion comprising hydrocortisone-21-acetate-17-propionate and selected water in oil emulsion; for use on dry skin |
| 08/05/1997 | US5653984 Extract of periwinkle seed and compositions containing the same |
| 08/05/1997 | US5653964 Dentinal desensitizing compositions |
| 08/05/1997 | US5653962 Aerosol formulations containing P134a and particulate medicaments |
| 08/05/1997 | US5653961 Butixocort aerosol formulations in hydrofluorocarbon propellant |
| 08/05/1997 | CA2132417C A crystalline modification of 2,4-dioxo-6-methyl-1, 2,3,4-tetrahydropyrimidine, a method for the preparation thereof and a medical preparation based on it |
| 08/05/1997 | CA1339221C Polyhydroxybenzoic acid derivatives |
| 08/05/1997 | CA1339220C Fatty acid analog enzyme substrates |
| 08/05/1997 | CA1339218C Silicon containing reaction product |
| 08/05/1997 | CA1339217C 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents |
| 08/05/1997 | CA1339216C Quinolone and naphthyridine antibacterial agents containing an alpha-amino acid in the side chain of the 7-substituent |
| 08/05/1997 | CA1339215C Rifapentine hydrohalides |
| 08/05/1997 | CA1339213C Substantially anhydrous crystalline cefadroxil and method for producing it |
| 08/05/1997 | CA1339198C Antibodies to the antigen campath-1 |
| 08/03/1997 | CA2196392A1 Tetrahydroisoquinoline derivatives |
| 08/01/1997 | CA2196488A1 Pharmaceutical composition for treatment of dementia |
| 07/31/1997 | WO1997027311A1 Mixture of recombinant vaccinia vectors as polyenv vaccines for hiv |
| 07/31/1997 | WO1997027301A1 Decorin binding protein compositions and methods of use |
| 07/31/1997 | WO1997027300A1 TOXOPLASMA GONDII ANTIGEN Tg20 |
| 07/31/1997 | WO1997027298A1 Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity |
| 07/31/1997 | WO1997027297A1 Inhibitors of cell-cycle progression, and uses related thereto |
| 07/31/1997 | WO1997027296A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
| 07/31/1997 | WO1997027220A2 Substrates and inhibitors for cysteine protease ich-1 |
| 07/31/1997 | WO1997027216A1 Amplification of response from expressed recombinant protein |
| 07/31/1997 | WO1997027211A1 Novel steroid carbamates as potentiating agents |
| 07/31/1997 | WO1997027210A1 New 19-nor-pregnene derivatives |
| 07/31/1997 | WO1997027208A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 07/31/1997 | WO1997027206A1 Oligonucleotide analogs |
| 07/31/1997 | WO1997027205A1 Imidazo[1,2-a]pyridine c-nucleosides as antiviral agents |
| 07/31/1997 | WO1997027204A1 Modified benzimidazole nucleosides as antiviral agents |
| 07/31/1997 | WO1997027202A1 Terpyridine-platinum(ii) complexes |
| 07/31/1997 | WO1997027201A1 Pyrido (3,2,1-ij)-1,3,4-benzoxadiazine |
| 07/31/1997 | WO1997027199A1 Pyrrolopyrimidines and processes for their preparation |
| 07/31/1997 | WO1997027192A1 3-methylimidazopyridines |
| 07/31/1997 | WO1997027191A1 Novel polymorphic forms of troglitazone having enhanced anti-diabetic activity and a process for their preparation |
| 07/31/1997 | WO1997027190A1 Thiazolylbenzofuran derivatives and pharmaceutical compositions containing them |
| 07/31/1997 | WO1997027188A1 Piperazinonephenyloxazolidinone derivatives and their use as antibacterial agents |
| 07/31/1997 | WO1997027186A1 1-pyrazol-3-yl-ethyl-4-indol-3-yl-piperidine used as medicine acting on the central nervous system |
| 07/31/1997 | WO1997027185A1 Piperidone tachykinin antagonists |
| 07/31/1997 | WO1997027183A1 Guanidine derivatives |
| 07/31/1997 | WO1997027181A1 Heterocyclo-substituted imidazoles for the treatment of inflammation |
| 07/31/1997 | WO1997027180A1 Aspartyl protease inhibitors |
| 07/31/1997 | WO1997027179A2 Antiretroviral bases |
| 07/31/1997 | WO1997027177A2 Dihydropyridine-, pyridine-, benzopyran-4-one- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists |
| 07/31/1997 | WO1997027176A1 Optical resolution of methylphenidate by 0,0'-bisaroyl tartaric acids |
| 07/31/1997 | WO1997027174A1 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 07/31/1997 | WO1997027049A1 Hyperpolarizable compounds and devices fabricated therefrom |
| 07/31/1997 | WO1997026968A2 Therapeutic anti-asthma agents containing selenium compounds |
| 07/31/1997 | WO1997026918A2 Ligand directed enzyme prodrug therapy |
| 07/31/1997 | WO1997026916A1 Obesity protein analog compounds and formulations thereof |
| 07/31/1997 | WO1997026915A1 Use of a thexaphyrin in the preparation of a medicament for use with a chemotherapeutic agent in cancer chemosensitization |
| 07/31/1997 | WO1997026914A1 Methods and compositions for passive immunotherapy |
| 07/31/1997 | WO1997026911A1 Malaria vaccine based upon the addition of a msa1 peptide |
| 07/31/1997 | WO1997026908A1 Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating helicobacter pylori infection |
| 07/31/1997 | WO1997026907A1 Novel administration of thrombopoietin |
| 07/31/1997 | WO1997026901A1 Regeneration of nerves in the central nervous system |
| 07/31/1997 | WO1997026896A1 Apoptosis inducers |
| 07/31/1997 | WO1997026894A1 Intravenous magnesium gluconate for treatment of conditions caused by excessive oxidative stress due to free radical distribution |
| 07/31/1997 | WO1997026893A1 Composition for treating cancer containing a ribose compound, beta-alanine, ascorbic acid and nicotinic acid |
| 07/31/1997 | WO1997026892A1 Combinations of peroxide lipids and organosilicon compounds, cosmetic and dermatological compositions containing same, and uses thereof, in particular for treating alopecia |
| 07/31/1997 | WO1997026891A1 Sphingolipids effective against bacteria, parasites, protozoans, fungi and viruses |
| 07/31/1997 | WO1997026890A1 Medicaments containing aromatic azo compounds |
| 07/31/1997 | WO1997026889A1 Method and composition for the potentiation of anti-inflammatory drugs |
| 07/31/1997 | WO1997026888A1 Use of squalamine and its analogues in ophthalmic compositions |
| 07/31/1997 | WO1997026887A1 Use of galanthamine in the preparation of novel drugs |
| 07/31/1997 | WO1997026886A1 Methods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria |
| 07/31/1997 | WO1997026885A1 Benzophenothiazine and benzoporphyrin dye combination photodynamic therapy of tumors |
| 07/31/1997 | WO1997026884A1 Method for treating sexual dysfunctions |
| 07/31/1997 | WO1997026883A1 Modulation of th1/th2 cytokine expression by ribavirin® and ribavirin® analogs in activated t-lymphocytes |
| 07/31/1997 | WO1997026882A1 Nucleoside analogs in combination therapy of herpes simplex infections |
| 07/31/1997 | WO1997026881A1 Method for inducing death of neoplastic cells using piperazine oxirane derivatives |
| 07/31/1997 | WO1997026880A2 Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients |
| 07/31/1997 | WO1997026879A1 Hydroxylamine compositions for the prevention or retardation of cataracts |
| 07/31/1997 | WO1997026878A1 Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) |
| 07/31/1997 | WO1997026877A1 Methods of inhibiting colon tumors |
| 07/31/1997 | WO1997026876A1 Methods of increasing sphincter competence |
| 07/31/1997 | WO1997026874A1 Use of fluvastatin derivatives in skin disease and topical compositions containing them |
| 07/31/1997 | WO1997026873A1 Antimicrobial aurone derivatives |
| 07/31/1997 | WO1997026872A1 Remedy for keratoconjunctival diseases |
| 07/31/1997 | WO1997026871A1 Method of treating undesired uterine contractions using optically pure r- or rr-isomers of adrenergic beta-2 agonists |
| 07/31/1997 | WO1997026867A2 Solid instant-release forms of administration and process for producing the same |
| 07/31/1997 | WO1997026866A2 Preparations of non-steroidal analgesics |
| 07/31/1997 | WO1997026863A1 Process for the production of powdered pulmonary surfactant preparations |
| 07/31/1997 | WO1997026862A2 Improved concentrated injection and infusion solutions for intravenous administration |
| 07/31/1997 | WO1997026858A1 Compounds based on squalene and sphingolipids effective against bacteria, parasites, protozoa, fungi and viruses |
| 07/31/1997 | WO1997026853A2 Dna encoding galanin galr2 receptors and uses thereof |
| 07/31/1997 | WO1997026804A1 Enteral formula or nutritional supplement containing arachidonic and docosahexaenoic acids |
| 07/31/1997 | WO1997026791A1 METHODS OF MODULATING RADICAL FORMATION BY MUTANT CuZnSOD ENZYMES |
| 07/31/1997 | WO1997026784A1 Induction of immune response against desired determinants |
| 07/31/1997 | WO1997022360A3 Control of protein synthesis, and screening method for agents |
| 07/31/1997 | WO1997018790A3 Therapeutic and diagnostic agents for the treatment of microbial infections |
| 07/31/1997 | WO1997015269A3 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 07/31/1997 | DE19604231A1 Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen A pharmaceutical combination preparation, and its use for the treatment of gynecological disorders |
| 07/31/1997 | DE19602989A1 Arzneimittel, enthaltend aromatische Azoverbindungen A medicament containing aromatic azo compounds |
| 07/31/1997 | DE19602971A1 New morphine derivatives |
| 07/31/1997 | DE19602970A1 New morphine derivatives |
| 07/31/1997 | DE19602969A1 New morphine derivatives |
| 07/31/1997 | DE19602968A1 New morphine derivatives |
| 07/31/1997 | DE19602965A1 New morphine derivatives |